Innlanz Limited, together with subsidiaries, engages in the retail sale of health and wellness products and supplements. The company operates through three segments: Retailer servicing the Chinese inbound tourism sector in Australia and New Zealand, Online sales through E-commerce Platform, and Hotel operations. It also operates retail stores. The company was formerly known as Mediland Pharm Limited. Innlanz Limited was founded in 2002 and is based in Parramatta, Australia.
Research context
Mediland Pharm Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Specialty Retail
- Industry
- Consumer Discretionary
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Mediland Pharm Limited is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 49.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.4.
Mediland Pharm Limited's total revenue sank by 96.3% to $727K since the same quarter in the previous year.
Its net income has dropped by 593.1% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 75.0% to $-536K since the same quarter in the previous year.
Based on the above factors, Mediland Pharm Limited gets an overall score of 2/5.